News

  • ARLG study helps physicians rapidly determine whether antibiotics will be effective against certain bacterial infections

    A recent study supported by the Antibacterial Resistance Leadership Group, (ARLG) called The Randomized Clinical Trial Evaluating Clinical Impact of RAPid Identification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN) was recently published in Clinical Infectious Diseases. This is the largest study to evaluate the clinical impact of rapid blood culture diagnostics in the management ... Read more
  • Vance Fowler honored with Distinguished Professorship from Duke School of Medicine

    Duke University School of Medicine awarded Vance Fowler, MD, MHS, the Florence McAlister Distinguished Professor of Medicine in 2020. Distinguished professorships recognize both exceptional achievement and the potential for future achievement.They are awarded to the most distinguished faculty who have demonstrated extraordinary scholarship in advancing science and improving human health. Read more
  • Cesar Arias Named New Editor in Chief of AAC Journal

    Antimicrobial Agents and Chemotherapy (AAC) announced that Cesar Arias, MD, PhD, will be its new editor in chief starting July 2020. Dr. Arias is part of the ARLG Laboratory Consortium team. He has received international recognition for his work conducting basic, translational and clinical research on antibiotic resistance. The AAC is an American Society for Microbiology ... Read more
  • CRACKLE-2 Study Results Published

    The World Health Organization (WHO) currently classifies carbapenem-resistant Enterobacterales (CRE) as one of the top three most dangerous multidrug-resistant pathogens. With the incidence of infections from CRE increasing dramatically since the first reported case in 1996, it is considered a significant public health threat. The Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae ... Read more

See More News